invasive breast cancer

美 [ɪnˈveɪsɪv brest ˈkænsər]英 [ɪnˈveɪsɪv brest ˈkænsə(r)]
  • 网络浸润性乳腺癌;乳腺浸润性癌
invasive breast cancerinvasive breast cancer
  1. Chemotherapy has became one principal method to therapy invasive breast cancer .

    化疗已成为浸润性乳腺癌的主要疗法之一。

  2. Conclusion : The adjuvant treatment of patients with primary invasive breast cancer is beneficial .

    结论:对早期浸润性乳腺癌妇女,使用辅助治疗还是有益的。

  3. Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance

    乳腺浸润性癌血管生成相关因子的表达及其临床意义

  4. Clinical Significance of Approximated Molecular Subtypes of Invasive Breast Cancer

    浸润性乳腺癌近似分子亚型的临床意义

  5. Multifactor analysis on the prognosis of invasive breast cancer

    浸润性乳腺癌预后的多因素分析

  6. Expression of cathepsin D in invasive breast cancer and its correlation with metastasis

    组织蛋白酶D在乳腺癌中的表达及其与转移的相关性研究

  7. Clinicopathological Significance of Tumor Angiogenesis in Invasive Breast Cancer

    乳腺癌肿瘤血管生成的临床病理学意义

  8. Characteristic of HER-2 in Beijing inpatients with invasive breast cancer

    北京市住院女性浸润性乳腺癌HER-2受体状态特征分析

  9. Expression of E-cadherin ,α - ,β - catenin in invasive breast cancer

    E-cadherin和α-catenin及β-catenin在乳腺癌组织中的表达及意义

  10. Expression and Significance of Beta 1 Integrin and ki-67 in Invasive Breast Cancer

    浸润性乳腺癌组织中整合素β1和ki-67的表达及其意义

  11. Main Outcome Measures Invasive breast cancer event ( recurrence or new primary ) or death from any cause .

    主要结果检测浸润性乳腺癌的发生(复发或者新发)或者任何原因的死亡。

  12. Correlation of angiogenesis and expression of cathepsin D with metastasis in invasive breast cancer

    乳腺癌血管生成及组织蛋白酶D表达与转移的关系

  13. Different standard of Her-2 / neu and its relationship with ER , RR and Ki-67 in invasive breast cancer

    乳腺癌Her-2/neu不同的评分标准与ER、PR及Ki-67的关系

  14. [ Background ] Worldwide , invasive breast cancer is the most common cancer in female and accounts for23 % of female cancers .

    [研究背景]浸润性乳腺癌是女性最常见的恶性肿瘤,在全球范围占女性癌症的23%。

  15. Methods By LSAB immunohistochemistry , MVC and pS2 expression in invasive breast cancer ( IBC ) were detected .

    方法:用LSAB法检测浸润性乳腺癌(IBC)中的微血管数(MVC)和pS2表达。

  16. This hypothesis was recently confirmed by a study that found a reduced risk of invasive breast cancer among postmenopausal women with high lignan levels in their diet , Clavel-Chapelon said .

    Clavel-Chapelon博士说,这种假说被近来的一项研究所证实,研究发现在绝经后的妇女中,饮食中含有高水平的木脂素类的人乳腺浸润性癌风险降低。

  17. Methods VEGF , TGF β 1 and CD34 expressions in 62 surgical specimens of invasive breast cancer and 12 normal breast specimens were examined by immunohistochemistry and HE staining .

    方法经手术治疗的乳腺浸润性癌62例及12例正常乳腺组织,分别进行HE染色和CD34、VEGF及TGFβ1的免疫组化染色。

  18. Results : ( 1 ) The positive rates of p53 in invasive breast cancer , noninvasive breast cancer and normal breast tissue are 71.6 % , 30.8 % and 0 % , respectively .

    浸润性乳腺癌、非浸润性乳腺癌及正常乳腺组织对照组中p53的阳性率分别是71.6%、30.8%和0%;

  19. In the high , medium , poorly degree of differentiation of invasive breast cancer , CD24 positive rates were respectively 30.7 % , 32.3 % and 34.2 % , which differences were no significant .

    在高、中、低分化不同分化程度的乳腺浸润性癌中,CD24阳性率分别为30.7%、32.3%及34.2%,不同分化程度的乳腺癌组织中CD24表达的差异无显著性意义(P0.05)。

  20. Objective To verify the correlation between mammographic features and expression of estrogen receptor ( ER ), progesterone receptor ( PR ) and human epidermal growth factor receptor 2 ( HER2 ) in invasive breast cancer .

    目的对浸润性乳腺癌的钼靶X线表现与雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)的表达状况进行比较,分析其相关性。

  21. Neoadjuvant chemotherapy is currently the standard of care for the management of locally advanced invasive breast cancer , because of its safety and efficacy , it has been more widely appreciated and applied in systemic treatment of breast cancer .

    新辅助化疗作为乳腺癌的重要治疗手段之一,因其安全性及疗效确切,已经在乳腺癌全身治疗中得到越来越广泛的重视和应用。

  22. Despite of the high expression of Survivin and Livin in invasive breast cancer tissues , there was no significant correlation between them , suggesting that the increased mechanism of Survivin and Livin is different in invasive breast cancer .

    虽然Survivin蛋白和Livin蛋白在浸润性乳腺癌组织中均呈高表达,但二者之间无明显相关,提示二者在浸润性乳腺癌组织中表达的上调机制有所不同。

  23. Recently , the American National Institute of Health stopped a clinical trial with HRT in healthy postmenopausal women after 5.2 years more than 3 years earlier than planned due to an increased risk of invasive breast cancer and of cardiovascular risks .

    据报道,由于浸润性乳腺癌和心血管疾病危险性的增加,美国国立卫生研究院提前三年结束了已经进行了5.2年的HRT在健康绝经妇女更年期综合征的临床试验。

  24. Conclusion The interaction between VEGF and TGF β 1 mediates angiogenesis , and MVC and VEGF and TGF β 1 expressions are correlated to lymph node metastasis , which may provide reference for prognostic evaluation of invasive breast cancer .

    结论VEGF和TGFβ1相互作用介导了肿瘤血管生成,MVC、VEGF和TGFβ1与淋巴结转移密切相关,可作为判断乳腺浸润性癌预后的参考指标。

  25. Significance of metallothionein expression in invasive ductal breast cancer

    乳腺癌组织中金属硫蛋白表达的意义

  26. The Prognosis of Molecular Subtypes in Invasive Ductal Breast Cancer

    乳腺癌分子分型在浸润性导管癌中的预后研究

  27. Changes of serum HIF-1 α and Gly-G in patients with invasive ductal breast cancer

    乳腺浸润性导管癌患者血清HIF-1α和Gly-G含量的变化及其意义

  28. Expression of Ezrin and E-cadherin in Invasive Ductal Breast Cancer and Their Correlations to Lymphatic Metastasis

    浸润性乳腺导管癌组织中Ezrin和钙粘素E的表达与淋巴结转移的关系

  29. This study was performed to detect the expression of Ezrin and E-cadherin in primary invasive ductal breast cancer in order to evaluate their possible roles in lymphatic metastasis .

    本研究通过检测Ezrin和钙粘素E(E-cadherin)在浸润性乳腺导管癌中的表达情况,探讨其在淋巴结转移中的意义。

  30. Objective To study the advances of minimally invasive surgery for breast cancer .

    目的探讨乳腺癌微创治疗新进展。